Osteopathic Treatment on Motor Development of Hypotonic Infants. (HYPOSTEO)

Comparison of Osteopathic Treatment Versus Simulation on Motor Development of Hypotonic Infants.

Interventional study involving the human at risk and minimal constraint (RIPH2), randomized single-blind comparing the impact of osteopathic treatment on the axial tone of the hypotonic infant versus simulation

Study Overview

Status

Recruiting

Conditions

Detailed Description

Children referred to the "Center Broussais" clinic for hypotonia are evaluated in terms of psychomotor development by a pediatrician competent in neuro-pediatrics. It is a cabinet for the care of children from 0 to 16 years.

Osteopaths and pediatricians work together in this office of which 50% are children with neurological disorders.

If osteopathic care is indicated, and for children with inclusion / non-inclusion criteria, the study will be offered to parents. In case of parental acceptance, children will be randomized in single blind to receive either an osteopathic treatment (osteo group) or a simulation (simulation group). Neither the parents nor the pediatrician will know the randomization group.

The osteopathic treatment or simulation will be performed in a standardized way according to a previously established protocol.

In both groups, a neurological evaluation of the axial tone will be performed by a pediatrician before randomization, at the end of the first consultation and at the end of the 3rd consultation, ie 3 consultations by a pediatrician.

If the child was drawn in the "simulation" group, three additional consultations will be offered at the end of the study to allow him to benefit from optimal osteopathic care

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Créteil, France, 94000
        • Recruiting
        • CHI Créteil
        • Contact:
          • Coraline GRISEL
      • Paris, France, 75014
        • Recruiting
        • Centre Broussais
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 months to 2 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:Age: 8 months-24 months corrected age Axial hypotonia in the neurological examination

  • Age (age corrected for prematurity) of motor development evaluated on the Denver II scale below chronological age
  • Proposal for osteopathic treatment by the pediatrician or treating physician

Exclusion Criteria:

  • • Fever, shock or recent fall (face, skull, spine) not medically investigated, persistent cyanosis, bulging or depressed fontanel, cervical stiffness, fever

    • Neuromuscular diseases without axial hypotonia
    • Not affiliated to a social security scheme
    • Refusal to participate in the study by parents

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Osteopatic treatment
An osteopatic treatment will be realised by osteopath
standardized osteopathic treatment
Placebo Comparator: simulated osteopathic treatment
A simulated ostepathic treatment will be realised by osteopath
standardized simulated osteopathic treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor development on the Denver II scale
Time Frame: at month 6
Comparison of the difference between chronological age (in corrected age) and motor development age on the Denver II motor scale in the 2 groups after 3 osteopathy consultations or simulation
at month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor development on the Denver II scale
Time Frame: at month 2
at month 2
Motor development on the Denver II scale
Time Frame: at month 4
at month 4
Satisfaction visual scale (from 0 to 10)
Time Frame: at month 6
comparison of parents satisfaction with a visual analogic scale in the 2 groups
at month 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 13, 2018

Primary Completion (Anticipated)

June 13, 2025

Study Completion (Anticipated)

January 13, 2026

Study Registration Dates

First Submitted

February 21, 2019

First Submitted That Met QC Criteria

February 21, 2019

First Posted (Actual)

February 22, 2019

Study Record Updates

Last Update Posted (Estimate)

May 4, 2023

Last Update Submitted That Met QC Criteria

May 3, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HYPOSTEO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypotonia

3
Subscribe